Covaxx Overview

  • Founded
  • 2020
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 950
Employees
  • Latest Deal Type
  • M&A

Covaxx General Information

Description

Developer of diagnostic tests and vaccines designed to cure COVID-19. The company's tests and vaccines provide accurate information on outbreak prevalence and are affordable, enabling healthcare community to make more informed decisions and contain any future infections.

Contact Information

Website
www.covaxx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Parent Company
Vaxxinity
Primary Office
  • 1717 Main Street
  • Suite 3388
  • Dallas, TX 75201
  • United States
+1 (307) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Covaxx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 02-Mar-2021 00.000 Completed Generating Revenue
2. Grant 29-Sep-2020 0000 00.000 Completed Generating Revenue
1. Seed Round 04-May-2020 $2.85M $2.85M Completed Generating Revenue
To view Covaxx’s complete valuation and funding history, request access »

Covaxx Executive Team (10)

Name Title Board Seat Contact Info
Jon Harrison Chief Strategy Officer
Chang Wang Ph.D Executive Founder & Chairperson, Scientific Committee
Gray Heppner MD Chief Medical Officer
Lou Reese Co-Founder & Co-Chief Executive Officer
Mei Mei Hu JD Co-Founder & Co-Chief Executive Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Covaxx Board Members (3)

Name Representing Role Since
Chang Wang Ph.D Covaxx Executive Founder & Chairperson, Scientific Committee 000 0000
Dakin Sloss Covaxx Board Member 000 0000
Peter Diamandis MD Self Co-Founder & Vice Chairman 000 0000
To view Covaxx’s complete board members history, request access »

Covaxx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Covaxx Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Formic Ventures Venture Capital Minority 000 0000 000000 0
Ministry of Health and Welfare (South Korea) Government 000 0000 000000 0
Pershing Square Foundation Other 000 0000 000000 0
Prime Movers Lab Venture Capital Minority 000 0000 000000 0
Tribe Capital Venture Capital Minority 000 0000 000000 0
To view Covaxx’s complete investors history, request access »

Ready to get started?

Request a free trial